In September of 2020 Alkor Bio Group of Companies – Russian designer and manufacturer of ELISA and PCR diagnostic kits - has been assessed for compliance with the International standard ISO 13485:2016.

In  the middle of  September, the Alkor Bio Group of Companies (St. Petersburg), a Russian developer and manufacturer of test-systems and equipment for laboratory diagnostics by ELISA, IHLA and PCR methods, received a registration certificate from the Federal Service for Surveillance in Healthcare (Roszdravnadzor) for new kit "SARS-CoV-2 ELISA-IgM" for the qualitative enzyme immunoassay for the determination of immunoglobulins M to the SARS-CoV-2 in human serum and plasma.

On September 3, 2020 Company Alkor Bio received registration certificate of Federal Service for Surveillance in Healthcare for the SARS-CoV-2EIA-IgG.

In  the middle of July, Alkor Bio Group of Companies received a registration certificate from Roszdravnadzor for the new kit of reagents "Intifica SARS-CoV-2" for the qualitative detection of SARS-CoV-2 coronavirus RNA by RT-PCR with fluorescence detection in real time.

TS-ML reagent is intended for collection, transportation and storage of clinical material for the subsequent nucleic acids isolation for PCR analysis. 

The “AllergoPRO IgE-specific control serum” kit is intended to confirm the quality of the assay for the quantitative determination of class E immunoglobulins (IgE) for a variety of specific protein allergens in a clinical sample. It should be used with the kit “Allergo ELISA-specific IgE” manufactured by Alkor Bio with using biotinylated allergens.